André van Maurik

Differential Susceptibility of Heart, Skin, and Islet Allografts to T Cell-Mediated Rejection

Nick D. Jones, Stuart E. Turvey, André van Maurik et al. · The Journal of Immunology · 2001 · 173 citations · Full text

T-regulatory Cell, Immunology, Tissue Transplantation +19

Cutting Edge: CD4+CD25+ Alloantigen-Specific Immunoregulatory Cells That Can Prevent CD8+ T Cell-Mediated Graft Rejection: Implications for Anti-CD154 Immunotherapy

André van Maurik, Manuela Herber, Kathryn J. Wood et al. · The Journal of Immunology · 2002 · 169 citations

CD40-CD40 Ligand-Independent Activation of CD8+ T Cells Can Trigger Allograft Rejection

Nick D. Jones, André van Maurik, Masaki Hara et al. · The Journal of Immunology · 2000 · 148 citations

A randomized, phase II study of sequential belimumab and rituximab in primary Sjögren’s syndrome

Xavier Mariette, Francesca Barone, Chiara Baldini et al. · JCI Insight · 2022 · 108 citations · Full text

Immunology, Ii Study, Immunotherapy +19

A randomised, single-blind, placebo-controlled, dose-finding safety and tolerability study of the anti-CD3 monoclonal antibody otelixizumab in new-onset type 1 diabetes

Bart Keymeulen, André van Maurik, João J. Oliveira et al. · Diabetologia · 2020 · 47 citations · Full text